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Abstract  
Terminalia chebula belonging to the family Combretaceae is called the "king of medicines" in Tibet and used in the treatment 
of various diseases such as diabetes, depression, memory loss, cardiovascular diseases, leprosy etc and also inhibits the 
growth of malignant tumors. T.chebula fruit is rich in phytochemical constituents such as tannins, flavonoids and essential oils. 
In the present study antimicrobial activity of aqueous fruit extract of T.chebula was evaluated by Agar well diffusion method 
against gram +ve (Bacillus sphaericus, Staphylococcus aureus), gram -ve (Pseudomonas aeruginosa, Proteus mirabilis, 
Salmonella typhimurium, Klebsiella pneumoniae, Proteus vulgaris, Escherichia coli) and fungal (Candida albicans) strains at 
different concentrations. Among the microbial strains evaluated P.mirabilis and K.pneumoniae were found to be the most 
sensitive, based on the results demonstrated from the inhibition zones. Thus, T.chebula fruit can be considered as a potential 
candidate for new antimicrobial drugs owing to its broad spectrum activity. 
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INTRODUCTION 
 
     Medicinal plants are used for treating various diseases since 
prehistory (1). Plants are rich source of phytochemicals such as, 
phenols, flavonoids, essential oils etc which act as antimicrobials. 
Last few decades have witnessed the development of several 
synthetic drugs, however, due to the increase in the bacterial 
resistance towards the existing chemotherapeutics attention has 
been drawn for exploration of new natural antimicrobials (2). The 
main advantage of using plant extracts is that, the crude extracts 
contain a mixture of compounds viz. phenols, acids, esters, 
aldehydes etc., for which it is difficult to develop resistance by 
bacteria unlike the synthetic antibiotics that contain a single 
compound (3). The world health organization has taken an initiative 
for the development of plant based health care products and making 
them available to maximum number of people (4). 
     Terminalia chebula Retz, (family Combretaceae) is a flowering 
evergreen tree attaining a height up to 30m and 
widely distributed throughout India, Burma and Srilanka. The dried 
ripe fruit of T. chebula also known as black myrobalan has been 
widely used in the treatment of asthma, sore throat, vomiting, 
bleeding etc (5) and displayed strong antimicrobial activity against 
Helicobactor pyroli (6) and Escherichia coli (7). Black myrobalan has 
reported to have antioxidant and free redical scavenging activities (8). 
T.chebula fruit contains an active compound called Chebulic acid 
which is a phenolic acid (9). The present study is aimed to evaluate 
the antimicrobial potential of aqueous fruit extract of Terminalia 
chebula at different concentration. 
MATERIALS AND METHODS 
Plant collection and Preparation of the sample 
 
     T. chebula fruits were collected locally from Farm wealth Bio-
tech, Hyderabad. The fruits were dried and 
milled to fine powder and extracted with water.  Filtered extract was 
lyophilized till drying. Lyophilisation enables concentration of plant 
components by evaporation under pressure and low temperature 
through lyophilizer. The lyophilized extract was stored at 4°C for 
further use. The extract at the concentration of 1mg was used for 
testing the activity. 
 
Antimicrobial assay 
 
     The antimicrobial activity of the extract was determined using 
the Agar well diffusion method (10). Pour plate technique was used 
with an inoculum size of 106 colony forming units (cfu)/ml of bacteria. 
A borer with a diameter of 8mm was used for making the wells in the 
MHA plates. The extracts ranging from 500µg to 2000µg 
concentrations were dispensed into each of the wells. Amikacin, a 
broad spectrum antibiotic at a concentration of 50μg was used as the 
positive reference standard. Sterile distilled water was used as a 
negative control. After 24h incubation period at 37°C the zones of 
inhibition around each well were measured. By comparing the 
inhibitory zones around the well the sensitivity of the pathogens 
towards the extracts was determined. All the experiments were 
performed in triplicate and analyzed. 
 
Microbial Cultures 
 
     Bacteriological media (Mueller Hinton Agar (MHA) & Mueller 
Hinton Broth (MHB)) were procured from Himedia. The microbial 
cultures- Staphylococcus aureus MTCC 7443, Bacillus sphaericus 
MTCC 511, Escherichia coli MTCC 7410, Pseudomonas aeruginosa 
MTCC 2295, Proteus mirabilis MTCC 425, Proteus vulgaris MTCC 
744, Salmonella typhimurium MTCC 98, Klebsiella pneumoniae 
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MTCC 3384 and Candida albicans MTCC 3017 were obtained from 
IMTECH, Chandigarh. All the cultures were maintained on Mueller 
Hinton agar at 4°C and sub-cultured every fortnight and reactivated 
in Mueller Hinton broth before the antimicrobial assay. 
 
Statistical analysis 
 
     Results were expressed as the mean ± standard deviation 
from the obtained triplicate data. The data was compared by least 
significant difference test using Statistical Analysis System (ver 9.1). 
 
RESULTS AND DISCUSSION 
 
     Plants synthesize a wide variety of secondary metabolites as 
part of defence mechanism against attack by insects, herbivores and 
microorganisms (11). Due to the increase in the incidence of 
antibiotic resistance among microbe, attention has been drawn in 
search of new drugs from different sources. One such source is the 
plant biodiversity, as these green medicines are nontoxic, healthier 
and safe, in comparison to the synthetic drugs. Terminalia chebula 
fruit extracts showed good antimicrobial activity against oral bacterial 
strains (12). Phytochemistry and various pharmacological properties 
of Terminalia chebula has been studied which provide scope for 
evaluation of this plant as medicinal agent against the human 
diseases (13). 
     In the present study the phytochemical constituent of the 
aqueous fruit extract of Terminalia chebula were analysed. Clinically 
important microorganisms were used to assess the activity of 
extracts. The antimicrobial activity of aqueous fruit extract of 
Terminalia chebula against the different strains has been illustrated 
in Table 1. The aqueous extracts have shown good activity towards 
all the pathogens showing its broad spectrum nature (Fig. 1)
 
 
Table 1. Antimicrobial activity of aqueous fruit extract of Terminalia chebula Retz. 
 
Micro-organisms Concentration (µg) Zone of inhibition of 
aqueous fruit extract (mm) 
Antibiotic (50µg) 
Gram positive  
 
  
Staphylococcus aureus 500 µg 
1000 µg 
1500 µg 
2000 µg 
11.5±0.34 
13.5±0.17 
15.66±0.15 
18.33±0.15 
 
31.23±0.15 
Bacillus sphaericus 500 µg 
1000 µg 
1500 µg 
2000 µg 
13.56±0.35 
14.8±0.17 
15.66±0.40 
18.33±0.15 
 
36.33±0.4 
Gram negative  
 
  
Escherichia coli 500 µg 
1000 µg 
1500 µg 
2000 µg 
13.46±0.30 
15.33±0.41 
16.4±0.26 
19.88±0.11 
 
34.53±0.32 
Pseudomonas aeruginosa 500 µg 
1000 µg 
1500 µg 
2000 µg 
14.83±0.35 
16.76±0.15 
17.36±0.15 
19.5±0.26 
 
32.2±0.36 
Salmonella typhimurium 500 µg 
1000 µg 
1500 µg 
2000 µg 
17.66±0.15 
18.33±0.32 
20.43±0.30 
22.66±0.15 
 
30.33±0.35 
Proteus vulgaris 500 µg 
1000 µg 
1500 µg 
2000 µg 
16.33±0.36 
17.8±0.55 
19.7±0.62 
21.9±0.55 
 
30.36±0.35 
Proteus mirabilis 500 µg 
1000 µg 
1500 µg 
2000 µg 
22.5±0.17 
24.66±0.15 
25.43±0.25 
26.56±0.28 
 
27.23±0.25 
Klebsiella pneumoniae 500 µg 
1000 µg 
1500 µg 
2000 µg 
18.73±0.49 
21.6±0.36 
22.66±0.25 
23.6±0.36 
 
30.2±0.26 
Fungal    
Candida albicans 500 µg 
1000 µg 
1500 µg 
2000 µg 
14.46±0.40 
15.33±0.32 
17.36±0.28 
18.53±0.35 
 
30.4±0.36 
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Fig 1. Antimicrobial activity of aqueous fruit extract of Terminalia chebula Retz 
 
 
 
Fig 2. Zone of inhibition of aqueous fruit extract of Terminalia chebula Retz (a) Proteus mirabilis (b) Klebsiella pneumoniae (c) & (d) Zone of inhibition of antibiotic (50µg) 
against Proteus mirabilis and Klebsiella pneumoniae. 
 
Amikacin served as the positive control. The inhibition zone of 
aqueous extract were in the range of 11.5±0.34mm - 18.33±0.15mm 
in gram +ve strains and 13.46±0.30mm - 26.56±0.28mm in gram 
negative strains and 14.46±0.40mm - 18.53±0.35mm in fungal strain. 
The highest zone of inhibition was obtained against Proteus mirabilis 
(26.56±0.28mm) (fig 2). The efficiency of the extracts can be seen 
from the zones of inhibition obtained against potent microbes like K. 
pneumoniae (23.6±0.36mm) and S. typhimurium (22.66±0.15mm). 
The most resistant organism in the present study was found to be P. 
aeruginosa (19.5±0.26mm). The permeability of the compounds and 
the resistance mechanisms displayed by the microbes could be the 
reason for the variable zones of inhibition exhibited by the organisms. 
In the previous reports the ethanolic extract of T. chebula fruit has 
demonstrated strong antimicrobial activity against multidrug resistant 
bacteria (14). 
 
 
CONCLUSIONS 
 
     In the present study the aqueous fruit extract of Terminalia 
chebula has displayed good antimicrobial activity against gram 
positive, gram negative and fungal microorganisms, displaying its 
potential in the development of new phytopharmaceuticals. As these 
drugs are plant based, they can be considered safe for human. 
However, since the experiment conducted were based on crude 
extract further studies are needed in this direction. 
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